Evidence map›Paper›PMID 35877235›Full record

ArticleCurrent oncology (Toronto, Ont.)2022

Genomically Silent Refractory Gastric Cancer in a Young Patient Exhibits Overexpression of CXCL5.

Jonathan Hernandez, Michael A Turner, Prerna Bali, Mojgan Hosseini, Michael Bouvet, Kaitlyn Kelly, Marygorret Obonyo

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Current oncology (Toronto, Ont.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. TRIF-IFN-I pathway iniScience · 2024
    Article
  3. Review
  4. Repurposed Drugs in Gastric Cancer.Molecules (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jonathan HernandezDepartment of Medicine, School of Medicine, University of California, San Diego, CA 92093, USA.
Michael A TurnerDepartment of Surgery, University of California, San Diego, CA 92093, USA.ORCID 0000-0001-8949-3136
Prerna BaliDepartment of Medicine, School of Medicine, University of California, San Diego, CA 92093, USA.ORCID 0000-0002-1243-8478
Mojgan HosseiniDepartment of Pathology, University of California San Diego, CA 92037, USA.
Michael BouvetDepartment of Surgery, University of California, San Diego, CA 92093, USA.
Kaitlyn KellyDepartment of Surgery, University of California, San Diego, CA 92093, USA.
Marygorret ObonyoDepartment of Medicine, School of Medicine, University of California, San Diego, CA 92093, USA.ORCID 0000-0001-8703-8404
University of California San Diego · US

Funding

UC San Diego RAPID Faculty Development Program in Infectious DiseasesR25AI147376 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ADRIANA H TREMOULET, Joann Trejo · 2020 to 2026
$2.5M
NIAID NIH HHS R25 AI147376
6 · The paper itself

Abstract

Gastric cancer is the third leading cause of cancer-related deaths, with more than one million new cases and approximately 841,000 deaths annually worldwide. We report a case of a young patient (25 years old) with an aggressive form of gastric cancer. The patient had previously been treated for

Indexed as

Helicobacter InfectionsHelicobacter pyloriStomach NeoplasmsAdultChemokine CXCL5Genetic TestingGerm-Line MutationHumansChemokine CXCL5CXCL5 protein, humanadvanced gastric cancerCDH1CXCL5Helicobacter pyloriyoung patient

Identifiers

PMID35877235
PMCPMC9320515
OpenAlexW4283827914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.